Compounds > y 27632
Page last updated: 2024-09-03

y 27632 and mdv 3100

y 27632 has been researched along with mdv 3100 in 2 studies

Compound Research Comparison

Studies
(y 27632)		Trials
(y 27632)		Recent Studies (post-2010)
(y 27632)		Studies
(mdv 3100)		Trials
(mdv 3100)		Recent Studies (post-2010) (mdv 3100)
1,92438911,5461821,502

Protein Interaction Comparison

ProteinTaxonomyy 27632 (IC50)mdv 3100 (IC50)
Gamma-aminobutyric acid receptor subunit piHomo sapiens (human)3
Gamma-aminobutyric acid receptor subunit deltaHomo sapiens (human)3
Prostate-specific antigenHomo sapiens (human)0.13
Androgen receptorHomo sapiens (human)0.8644
Gamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)3
Androgen receptorRattus norvegicus (Norway rat)0.8238
Gamma-aminobutyric acid receptor subunit beta-1Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)3
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)1.26
Gamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-5Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-3Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-4Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit epsilonHomo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-6Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit gamma-1Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit gamma-3Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit thetaHomo sapiens (human)3

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Bai, Y; Chen, X; Cheng, L; Feng, F; Han, T; Huang, C; Kong, Y; Li, C; Liu, J; Liu, X; Wang, R; Zhang, Z1

Other Studies

2 other study(ies) available for y 27632 and mdv 3100

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration-resistant prostate cancer.
    The Prostate, 2020, Volume: 80, Issue:3

    Topics: Amides; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Line, Tumor; Cell Movement; Drug Resistance, Neoplasm; Drug Synergism; Humans; Male; Mice; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Pyridines; Random Allocation; Receptors, Androgen; rho-Associated Kinases; Wnt Signaling Pathway; Xenograft Model Antitumor Assays

2020